Ampicillin/sulbactam-induced Kounis syndrome with cardiogenic shock. 2017

Nicholas G Kounis, and Ioanna Koniari
Department of Cardiology, University of Patras Medical Schhol; Patras-Greece. ngkounis@otenet.gr.

UI MeSH Term Description Entries
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074962 Kounis Syndrome A disorder of cardiac function secondary to hypersensitivity reactions. It is characterized by coexistence of acute coronary syndromes and cardiac MAST CELL and PLATELET ACTIVATION. It may be induced by exposure to drugs (e.g., antibiotics, anesthetics, contrast media), food, and environmental triggers (e.g., insect bites and stings, poison ivy). Allergic Acute Coronary Syndrome,Allergic Angina Syndrome,Allergic Myocardial Infarction,Allergic Angina Syndromes,Allergic Myocardial Infarctions,Myocardial Infarction, Allergic
D000667 Ampicillin Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. Penicillin, Aminobenzyl,Amcill,Aminobenzylpenicillin,Ampicillin Sodium,Ampicillin Trihydrate,Antibiotic KS-R1,Omnipen,Pentrexyl,Polycillin,Ukapen,Aminobenzyl Penicillin,Antibiotic KS R1,KS-R1, Antibiotic,Sodium, Ampicillin,Trihydrate, Ampicillin
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012770 Shock, Cardiogenic Shock resulting from diminution of cardiac output in heart disease. Cardiogenic Shock
D013407 Sulbactam A beta-lactamase inhibitor with very weak antibacterial action. The compound prevents antibiotic destruction of beta-lactam antibiotics by inhibiting beta-lactamases, thus extending their spectrum activity. Combinations of sulbactam with beta-lactam antibiotics have been used successfully for the therapy of infections caused by organisms resistant to the antibiotic alone. Bétamaze,CP-45899,Combactam,Penicillanic Acid Sulfone,Sulbactam Sodium,CP 45899,CP45899,Sodium, Sulbactam,Sulfone, Penicillanic Acid

Related Publications

Nicholas G Kounis, and Ioanna Koniari
January 2022, Frontiers in cardiovascular medicine,
Nicholas G Kounis, and Ioanna Koniari
November 2011, Journal of cardiovascular medicine (Hagerstown, Md.),
Nicholas G Kounis, and Ioanna Koniari
April 2023, Heliyon,
Nicholas G Kounis, and Ioanna Koniari
October 2013, Cardiovascular journal of Africa,
Nicholas G Kounis, and Ioanna Koniari
December 2012, Revista espanola de cardiologia (English ed.),
Nicholas G Kounis, and Ioanna Koniari
November 1994, Circulatory shock,
Nicholas G Kounis, and Ioanna Koniari
March 2013, Journal of cardiology cases,
Nicholas G Kounis, and Ioanna Koniari
January 2019, Case reports in critical care,
Nicholas G Kounis, and Ioanna Koniari
December 2015, Coronary artery disease,
Copied contents to your clipboard!